Auxo Firm Directory · Independent Research Profile

Wellspring Capital

Wellspring Capital Management rebranded as Revelar Capital in October 2025. Revelar describes a private equity model focused on North America-based, middle-market businesses and value creation through strategic initiatives, operational improvements, talent investment and add-on acquisitions.

Key takeaway

What stands out about Wellspring Capital

Wellspring Capital, now operating as Revelar Capital, invests across healthcare services, essential services and specialty manufacturing. Its stated focus is on North America-based, middle-market businesses, including overlooked businesses in complex, fragmented industries where growth, operational improvement and further M&A may be pursued.[1][2][5][6][7]

What does Wellspring Capital invest in?

Revelar Capital is the rebranded identity of Wellspring Capital Management, announced on October 15, 2025. The firm now operates as Revelar Capital.

Revelar describes itself as a private equity firm that partners with North America-based, middle-market businesses. Its stated support includes strategic initiatives, operational improvements and add-on acquisitions intended to support growth.[1][2]

Revelar states that it invests exclusively across healthcare services, essential services and specialty manufacturing. Its approach uses strategic initiatives, operational improvements and add-on acquisitions to unlock growth.

The firm also describes investments in overlooked businesses in complex, fragmented industries, with potential value-creation activity including talent investment and further M&A.[1]

Owners evaluating a financial buyer can compare the offer with independent valuation analysis, understand how acquirers approach transactions through Auxo’s buy-side M&A process guide, and consider whether a full or partial sale best fits their objectives.

Public size / criteria information
Revelar reports $4.6 billion in AUM as of December 31, 2025, adjusted for post-Q4 activity, more than 25 team members and 16 years of average partner tenure. It describes its target businesses as middle-market companies and seeks overlooked businesses in complex, fragmented industries.[1][2]

What should a business owner evaluate before considering a transaction with Wellspring Capital?

For an owner evaluating a sale or partnership, Revelar’s stated parameters include North America-based, middle-market businesses in healthcare services, essential services and specialty manufacturing. The firm describes an approach that may include strategic initiatives, operational improvements, talent investment and add-on acquisitions.

Owners should clarify the applicable size and equity-investment parameters by sector, the available ownership and rollover structures, the expected ownership horizon and exit-planning approach, the allocation of follow-on capital, and the operating resources and governance arrangements associated with a transaction.[1][2]

01

What are the current target enterprise-value, EBITDA, revenue and equity-investment ranges by sector

Revelar publicly describes a North America-based, middle-market focus but does not establish these specific financial ranges in the cited claims.[1][2]
02

Does Revelar require control, and what minority or rollover structures are available

The public claims describe private equity partnership and platform or add-on activity but do not specify the ownership structures available for every transaction.[2][5][6]
03

What is the expected ownership horizon and exit-planning approach for a new platform investment

The cited claims identify platform investments and the firm’s investment approach but do not establish an ownership-duration or exit-planning policy.[1][5][6]

What companies does Wellspring Capital target?

Revelar describes its target businesses as North America-based, middle-market companies. It seeks overlooked businesses in complex, fragmented industries where it can support growth through strategic initiatives, operational improvements, talent investment and further M&A.

Revelar reports $4.6 billion in AUM as of December 31, 2025, adjusted for post-Q4 activity, more than 25 team members and 16 years of average partner tenure.[1][2]

Healthcare services subsectors identified by Revelar include home-based care, outpatient specialty care, infusion and specialty pharmacy, imaging and diagnostics, pharma services, and rehabilitation and therapy services.

Its specialty manufacturing themes include packaging, automation solutions, safety products, automotive aftermarket, specialty industrial and precision components. The firm also identifies essential services as a sector of investment.[1][3][4]

Revelar states that it partners with North America-based, middle-market businesses. The firm lists offices in New York and Palm Beach.[2]

Revelar’s public announcements distinguish between platform investments and subsequent strategic add-ons. Its December 18, 2025 announcement described Lettermen’s Energy as the firm’s fifth platform investment in 18 months and named Mile High Propane and Aspen Valley Propane as subsequent strategic add-ons.

On April 20, 2026, Revelar announced that portfolio company Steele Solutions acquired Maysteel Industries. The official portfolio framework covers investments made since the beginning of 2022 and selected WCP Fund V and WCP Fund VI investments for which current Revelar partners controlled investing activities.[5][6][7]

The official Revelar portfolio page represents investments made since the beginning of 2022, along with selected WCP Fund V and WCP Fund VI investments for which current Revelar partners controlled investing activities.

Publicly identified examples include Lettermen’s Energy and Steele Solutions. The Lettermen’s Energy announcement also names Mile High Propane and Aspen Valley Propane as subsequent strategic add-ons. Revelar announced that Steele Solutions acquired Maysteel Industries.[5][6][7]

Revelar announced the acquisition of Lettermen’s Energy on December 18, 2025. The announcement described it as the firm’s fifth platform investment in 18 months and named Mile High Propane and Aspen Valley Propane as subsequent strategic add-ons.

The official portfolio-updates archive lists an acquisition announcement for Golden State Medical Supply dated April 15, 2026. On April 20, 2026, Revelar announced that portfolio company Steele Solutions acquired Maysteel Industries.[6][7][8]

What is not clear from Wellspring Capital's public investment criteria?

The Lettermen’s Energy acquisition announcement states that financial terms were not disclosed. The Maysteel Industries acquisition announcement likewise states that financial terms were not disclosed.

The official portfolio page does not publish purchase price, financing, valuation or ownership-percentage details for the listed portfolio investments.[5][6][7]

Questions to ask when evaluating Wellspring Capital as a buyer or investment partner

What are the current target enterprise-value, EBITDA, revenue and equity-investment ranges by sector?
Revelar publicly describes a North America-based, middle-market focus but does not establish these specific financial ranges in the cited claims.[1][2]
Does Revelar require control, and what minority or rollover structures are available?
The public claims describe private equity partnership and platform or add-on activity but do not specify the ownership structures available for every transaction.[2][5][6]
What is the expected ownership horizon and exit-planning approach for a new platform investment?
The cited claims identify platform investments and the firm’s investment approach but do not establish an ownership-duration or exit-planning policy.[1][5][6]
How much follow-on capital is typically reserved for add-ons and organic investment?
Revelar identifies add-on acquisitions as part of its strategy and has publicly named subsequent strategic add-ons, but the cited claims do not specify follow-on capital amounts.[1][6]
Which operating resources are assigned to a portfolio company, and how are management incentives, rollover equity, governance rights and add-on integration responsibilities structured?
Revelar describes strategic initiatives, operational improvements, talent investment and add-on M&A, while the cited public portfolio information does not specify these transaction-level arrangements.[1][5]

Sources & research notes

Public-source research
  1. Official website / firm overview
  2. Services / capabilities
  3. Industry / market focus
  4. Industry / market focus
  5. Transaction / portfolio evidence
  6. Transaction / portfolio evidence
  7. Transaction / portfolio evidence
  8. Transaction / portfolio evidence
  9. SEC filing / regulatory record
Prepared and reviewed by: Auxo Capital AdvisorsEvidence standard: Public-source verification

How this profile was researched

Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.

Independent profile & regulatory context

Independent research profile

This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.

Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.

Broker-dealer and securities disclosure

Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.

Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.

Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.

Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.